James A. Whitlock

11.3k citations

141 papers · 5.1k indexed · 2 hit papers · h-index 39

Impact in

Hematology top 1%
- Acute Myeloid Leukemia Research
Pediatrics, Perinatology and Child Health top 0.5%
- Childhood Cancer Survivors' Quality of Life

Papers in

Hematology 40
- Acute Myeloid Leukemia Research 23
Genetics 23
- Chronic Lymphocytic Leukemia Research 11
- Glioma Diagnosis and Treatment 10

Co-authors: John P. Greer Meenakshi Devidas Stephen P. Hunger Robert J. Goldberg Harold L. Kennedy Michael K. Sprague Thomas A. Buckingham Lisa Kennedy
Journals: Blood (28 papers)Pediatric Blood & Cancer (21 papers)Journal of Clinical Oncology (19 papers)Journal of Pediatric Hematology/Oncology (5 papers)British Journal of Haematology (4 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

James A. Whitlock

138 papers receiving 4.9k citations

Hit Papers

align trajectories log scale

Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia 2021 · 207 citations

Peers

Countries citing papers authored by James A. Whitlock

Since Specialization

Citations

This map shows the geographic impact of James A. Whitlock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Whitlock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Whitlock more than expected).

Fields of papers citing papers by James A. Whitlock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Whitlock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Whitlock. The network helps show where James A. Whitlock may publish in the future.

Co-authors

The 25 scholars most cited alongside James A. Whitlock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James A. Whitlock Line = papers co-authored together James A. Whitlock links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse Journal of Clinical Oncology ·Laura Hogan, Patrick A. Brown, Lingyun Ji, Xinxin Xu, Meenakshi Devidas, Teena Bhatla, Michael J. Borowitz, Elizabeth A. Raetz, Andrew J. Carroll, Nyla A. Heerema, Gerhard Zugmaier, Elad Sharon, M. Brooke Bernhardt, Stephanie Terezakis, Lia Gore, James A. Whitlock, Stephen P. Hunger, Mignon L. Loh	2023	33
2	A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in Low Risk (LR) First Relapse of B-Acute Lymphoblastic Leukemia (B-ALL) in Children and Adolescents/Young Adults (AYAs): A Report from Children's Oncology Group Study AALL1331 Blood ·Patrick A. Brown, Lingyun Ji, Xinxin Xu, Meenakshi Devidas, Laura Hogan, Teena Bhatla, Michael J. Borowitz, Elizabeth A. Raetz, Lia Gore, James A. Whitlock, Stephen P. Hunger, Mignon L. Loh	2021	7
3	Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group phase III study AALL0433 Haematologica ·Glen Lew, Yichen Chen, Xiaomin Lu, Susan R. Rheingold, James A. Whitlock, Meenakshi Devidas, Caroline A. Hastings, Naomi Winick, William L. Carroll, Brent L. Wood, Michael J. Borowitz, Michael A. Pulsipher, Stephen P. Hunger	2020	24
4	First report of t(5;11) KMT2A-MAML1 fusion in de novo infant acute lymphoblastic leukemia Cancer Genetics ·Sneha Tandon, Mary Shago, Scott Davidson, Nisha Kanwar, Fabio Fuligni, Adam Shlien, James A. Whitlock, Anita Villani, Oussama Abla	2020	3
5	A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk (HR/IR) First Relapse of B-Acute Lymphoblastic Leukemia (B-ALL) in Children and Adolescents/Young Adults (AYAs) Demonstrates Superior Efficacy and Tolerability of Blinatumomab: A Report from Children's Oncology Group Study AALL1331 Blood ·Patrick A. Brown, Lingyun Ji, Xinxin Xu, Meenakshi Devidas, Laura Hogan, Michael J. Borowitz, Elizabeth A. Raetz, Gerhard Zugmaier, Elad Sharon, Lia Gore, James A. Whitlock, Michael A. Pulsipher, Stephen P. Hunger, Mignon L. Loh	2019	51
6	Clinical decisions following implementation of asparaginase activity monitoring in pediatric patients with acute lymphoblastic leukemia: Experience from a single‐center study Pediatric Blood & Cancer ·Laura Pérez Lago, David Colantonio, 骆昌芹, Ahmed Naqvi, Johann Hitzler, James A. Whitlock, L. Lee Dupuis	2019	3
7	Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation–Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study Clinical Cancer Research ·Darren Hargrave, Éric Bouffet, Uri Tabori, Alberto Broniscer, Kenneth J. Cohen, Jordan R. Hansford, Birgit Geoerger, Pooja Hingorani, Ira J. Dunkel, Mark W. Russo, Lillian Tseng, Kohinoor Dasgupta, Eduard Gasal, James A. Whitlock, Mark W. Kieran	2019	125
8	A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation–Positive Solid Tumors Clinical Cancer Research ·Mark W. Kieran, Birgit Geoerger, Ira J. Dunkel, Alberto Broniscer, Darren Hargrave, Pooja Hingorani, Isabelle Aerts, Layssa de Moura Oliveira, Kenneth J. Cohen, Trent R. Hummel, Violet Shen, Éric Bouffet, Christine A. Pratilas, Andrew D.J. Pearson, Lillian Tseng, Noelia Nebot, Steven Green, Mark W. Russo, James A. Whitlock	2019	58
9	CNS tumours The first study of dabrafenib in pediatric patients with BRAF V600–mutant relapsed or refractory low-grade gliomas Annals of Oncology ·Mark W. Kieran, Éric Bouffet, Uri Tabori, Alberto Broniscer, Kenneth J. Cohen, Jordan R. Hansford, Birgit Geoerger, Pooja Hingorani, Ira J. Dunkel, Mark W. Russo, Lillian Tseng, Nabil Daddaouda, Noelia Nebot, James A. Whitlock, Darren Hargrave	2016	13
10	Clinical and Radiographic Improvement of Neurodegenerative Langerhans Cell Histiocytosis (ND-LCH) Following Dabrafenib (P3.266) Neurology ·E. Ann Yeh, Sarah Leary, Giulia Longoni, Oussama Abla, Nadine Stouvenakers, James A. Whitlock	2016	1
11	Updates on histiocytic disorders Pediatric Blood & Cancer ·Sarah R. Vaiselbuh, Yenan T. Bryceson, Carl E. Allen, James A. Whitlock, Oussama Abla	2014	65
12	Initial Results from a Phase 2 Study of Blinatumomab in Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia Blood ·Lia Gore, Franco Locatelli, Gerhard Zugmaier, C. Michel Zwaan, Deepa Bhojwani, Rupert Handgretinger, Peter Bader, Maureen M. O’Brien, Tanya Trippett, Benoît Brethon, Carmelo Rizzari, Steven G. DuBois, Paul G. Schlegel, Phillip Barnette, Chiara Messina, Kuolung Hu, Noemi Mergen, Anja Fischer, James A. Whitlock, Arend von Stackelberg	2014	19
13	Targeting the Bcl-2 family of proteins in Hodgkin lymphoma:*in vitrocytotoxicity, target modulation and drug combination studies of the Bcl-2 homology 3 mimetic ABT-737 Leukemia & lymphoma* ·Aarthi Jayanthan, Scott C. Howard, Tanya Trippett, Terzah M. Horton, James A. Whitlock, L. Bartalits, Victor Lewis, Aru Narendran	2009	16
14	Executive Function, Coping, and Behavior in Survivors of Childhood Acute Lymphocytic Leukemia Journal of Pediatric Psychology ·Laura K. Campbell, Maria Cristina Scaduto, Seema Nath, EricP Roger, James A. Whitlock, Bruce E. Compas	2008	100
15	Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952 Pediatric Blood & Cancer ·NICOLA SOLAR, Mei La, James A. Whitlock, Harland N. Sather, Nyla A. Heerema, Paul S. Gaynon, Linda C. Stork	2004	50
16	Detection of mutations by automated fluorescence/RNA-based dideoxy fingerprinting (ARddF) Oncogene ·Danko Martincic, Mark J. Koury, PriyankaBhatia, James A. Whitlock	1999	3
17	High-dose cytosine arabinoside and etoposide: an effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemia Leukemia ·James A. Whitlock, Margarita Kazak, R. Karatschai, Adarsh R. Ettyreddy, JP Greer, Luísa Cunha Silva, Pengfei Hu, С Т Артемова, Claritza Viviana Núñez Perea	1997	14
18	Long-Term Granulocyte-Macrophage Colony-Stimulating Factor and Immunosuppression in the Treatment of Acquired Severe Aplastic Anemia Journal of Pediatric Hematology/Oncology ·Jeffrey D. Hord, James C. Gay, James A. Whitlock, Robert L. Janco, John R. Edwards, John P. Greer, John N. Lukens	1995	13
19	Cloning, Characterization and Sequencing of two Haemagglutinin Genes from Eikenella Corrodens Journal of General Microbiology ·Gong-Ping Zhang, James A. Whitlock, John Bromer	1993	7
20	Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia Cancer ·James A. Whitlock, John P. Greer, John N. Lukens	1991	150

About James A. Whitlock

James A. Whitlock is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Oncology, having authored 141 papers that have together received 5.1k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (58 papers), Childhood Cancer Survivors' Quality of Life (31 papers), Acute Myeloid Leukemia Research (23 papers), Histiocytic Disorders and Treatments (15 papers), Neuroblastoma Research and Treatments (14 papers), Chronic Lymphocytic Leukemia Research (11 papers), Glioma Diagnosis and Treatment (10 papers) and Cancer therapeutics and mechanisms (10 papers). The work is most often cited by research in Hematology (1.0k citations), Pediatrics, Perinatology and Child Health (1.3k citations), Public Health, Environmental and Occupational Health (1.8k citations), Genetics (643 citations) and Oncology (1.2k citations). James A. Whitlock has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include John P. Greer, Meenakshi Devidas, Stephen P. Hunger, Robert J. Goldberg, Harold L. Kennedy, Michael K. Sprague, Thomas A. Buckingham, Lisa Kennedy, John N. Lukens and Elizabeth A. Raetz. Their work appears in journals such as Blood, Pediatric Blood & Cancer, Journal of Clinical Oncology, Journal of Pediatric Hematology/Oncology and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact